In this study, we determined a lower ADL cut‐off concentration of 6.8 mg/L to be associated with biochemical remission in Crohn's disease, using CRP and f‐calprotectin as a composite surrogate disease activity marker. This evidence concerns the gene CRP and Crohn disease.